Innitius

🌍 Prematurity Awareness Month: A Global Call to Action for Preterm Births 🌍 November marks #PrematurityAwarenessMonth—a reminder of the pressing need to address the global crisis of preterm birth. Each year, 13.4 million babies are born too soon, with nearly 1 million of them tragically lost due to complications. Preterm birth is the leading cause of death for children under 5, highlighting urgent areas for action. The World Health Organization and UNICEF’s latest “Born Too Soon” report provides a clear call to action: 1️⃣ Improve Quality of Care: Investing in healthcare infrastructure and training ensures that #newborns receive the care they need, especially in underserved regions. 2️⃣ Tackle #Inequities: 65% of preterm births occur in low-resource settings, notably South Asia and sub-Saharan Africa. Addressing healthcare inequities is essential to improve outcomes for all. 3️⃣ Enhance Data Collection: Better data can guide targeted interventions and support policies to reduce preterm birth rates. 4️⃣ Collaborate and Invest: Governments, organizations, and the private sector must come together to support innovations in maternal and neonatal health. 5️⃣ Drive Policy Reforms: Policies that address maternal health and environmental factors, like pollution, can help mitigate risks associated with preterm birth. Let’s work together to create a world where every baby has a healthy start in life! 🌟 #PrematurityAwareness #BornTooSoon #GlobalHealth #MaternalHealth #PretermBirth

🔵 Are you interested in an investment opportunity that is transforming the future of women’s health? Our CEO, Rubén Molina, invites you to discover Innitius and how we’re revolutionizing the diagnosis and treatment of obstetric conditions with innovative, validated technology. In this video, Rubén shares INNITIUS's vision, our progress, and the unique opportunity to be part of our growth in the medical device sector. 🚀 Don’t miss the chance to support a company making a real difference in the lives of millions of women worldwide. 👉 Press play to learn more about the future of women’s health with INNITIUS! https://lnkd.in/dYfGqZNG #womenshealth #pregnancycare #pretermbirth #preemies #medicaldevice #startup

Did you know that preterm birth is the leading cause of death in children under five years worldwide? Every year, 15 million babies are born prematurely, and 1 million of them lose their lives. The impact on families and healthcare systems is enormous and calls for innovative solutions to make a difference. At Innitius, we're dedicated to developing technology that supports healthcare professionals in making critical, accurate decisions during pregnancy. We are proud to see our work highlighted in this Femtech Real Money Talks post, as we strive to improve outcomes for mothers and infants everywhere. Our mission is clear: to drive progress in women’s health with solutions that can potentially save lives and improve long-term health outcomes. Together, let's continue the fight against preterm labor. #WomenHealth #MedicalDevices #Innovation #PretermLabor #Healthcare

🎉 Exciting News! 🎉 We’re thrilled to announce that Innitius has been selected as a finalist in the Women’s Health Track at the prestigious Health Tech Challengers competition! 🌟 This recognition comes on the heels of the positive results from our clinical study, and we couldn’t be more excited to share this journey with other amazing companies working toward transforming women's health. We’re incredibly grateful to be part of this event and are looking forward to competing alongside such innovative startups at the pitch battle in Barcelona on December 4th and 5th. 🚀 Thank you to everyone who has supported us, and we can't wait to see what’s next! Tickets available: https://lnkd.in/diadRzv #HealthTechChallengers #WomensHealthInnovation #Innitius #Finalists #InnovationInHealthcare

🔍 Preterm birth risk: Personal vs. Family History Did you know that your personal history of preterm birth has a much stronger influence on your risk than your family history? 📊 Swipe through to see the details! At Innitius, we’re dedicated to early identification and personalized care for mothers and babies. 💙 #PretermBirth #MaternalHealth #PersonalizedCare #Innitius #HealthcareInnovation #WomenInHealth #MedicalResearch

🚀 Exciting News for Investors! 🚀 Our CEO, Rubén Molina, will be hosting an exclusive webinar on October 21st to discuss an investment opportunity in Innitius, the startup leading the way in revolutionizing women’s health diagnostics with Torsional Waves technology. 👩⚕️ Discover how our solutions are transforming prenatal and gynecological healthcare, and learn about the incredible growth potential we offer for Business Angels and Family Offices. 📅 Date: Monday, October 21st, 2024 ⏰ Time: 5:00pm 🔗 Register now: https://lnkd.in/d-rq_CXa Join us and be part of the future of women’s health! 🌟 #InvestmentOpportunity #WomensHealth #HealthcareInnovation #Innitius 

🎉 Exciting News! 🎉 Our CEO, Rubén Molina, will be heading to Berlin this weekend for Frontiers Health 2024 on October 17-18! He’s looking forward to connecting with innovators, healthcare leaders, and fellow entrepreneurs to explore the future of health tech and women’s health. ✨ If you’re attending #FH24, don’t hesitate to reach out! Let’s connect and exchange ideas about how we can continue improving women’s health through groundbreaking solutions. Let’s make an impact together – see you in Berlin! 🚀 #FrontiersHealth2024 #HealthcareInnovation #WomensHealth #HealthTech #Innitius

While the days might be getting shorter, the LSI Alumni’s list of accomplishments keeps growing longer. This week the #LSIAlumni secured new funding, received FDA Breakthrough Device Designation, appointed new board members, and much more on the road to LSI USA ‘25. Your 60-second news recap: 4C Medical Technologies, Inc. — Saravana Kumar → Commenced enrollment in the A Transseptal Left Atrial System for Treatment of Mitral Regurgitation (ATLAS) trial in the United States and Europe. AccurKardia — Juan C Jimenez, Mohamed Sadeq Ali → Received FDA Breakthrough Device Designation for its ECG-based, AI-powered aortic valve stenosis screening software. CardiaCare — Amos Ziv → Enrolled the first patient in its NeuroPulse Post-Ablation clinical trial with Mount Sinai Health System. InspireMD — Shane Gleason → Announced IDE application approval from the FDA to initiate its CGUARDIANS II pivotal study. Innitius — Rubén Molina → Announced the latest results from its FB-CT1 clinical study assessing the usability and efficacy of its FineBirth device in predicting preterm labor risk. Lymphatica Medtech — Marco Pisano → Raised a €17.9M Series B funding round co-lead by LSI Alumni investor Panakes Partners, TechWald Next S.p.A, and CDP Venture Capital SGR's Digital Transition Fund. Reprieve Cardiovascular — Mark Pacyna → Completed enrollment in the Fluid Management of Acute Decompensated Health Failure Subjects Treated with Reprieve System (FASTR) trial. SymPhysis Medical — Tim Jones → Secured €2.2M in funding for developing its digital catheter-based device for treating fluid buildup in the body due to late-stage cancers. Vitestro — Toon Overbeeke → Appointed LSI Alumni Dave Hickey to its Board of Directors as an independent board member. Congratulations to all the LSI Alumni who made major milestones this week!

🤔 Curious what's been up in the world of femtech and women's health innovation this week? Here's the our run-down! 👇 🚀 Panasonic Well Launches $1 Million Family Wellness Challenge. https://lnkd.in/gJYKsRQU 💰 Maven Clinic raises $125M in Series F, becomes highest valued digital health company in women's and family health. https://lnkd.in/gcrQtMne 🔍 LEVY Health secures $4.5M seed funding to accelerate fertility diagnosis. https://lnkd.in/gNb_Apdu 👩👩👦 Rezilient Health raises $10M Series A to expand tech-enabled family healthcare model. https://lnkd.in/g8WMkveK 🔴 Canada-based Marlow secures $1.9M for novel lubricated tampon product. https://lnkd.in/e--zRp9P 🌱 FLORA (Flora Fertility) raises $1.5M to launch fertility insurance product. https://lnkd.in/g2Nehgvy 💰SimX secures $1.25M from AFWERX, DAF's innovation arm, for VR-based women's health training. https://lnkd.in/gRrui9NV 🚀 Sollis Health launches family membership for integrated emergency and everyday care. https://lnkd.in/gDz3u6hV 🔬 Consumer health startup Beli expands from supplements to at-home fertility testing for men and women. https://lnkd.in/gAXxECjE 🍼 Harbor introduces Remote Nanny Service for affordable overnight infant care. https://lnkd.in/gK9uMFsh 🤰 Innitius's Fine Birth Device shows promise in preterm labor diagnosis. https://lnkd.in/gDsCtHt5 🚀 RH Capital Team launches Foreground Capital; a new chapter in women's health investing. https://lnkd.in/gEixK9pn Want to learn more? We've collected the links to all stories (and more!) in the article below: 👇 https://lnkd.in/g2-spGbJ #femtech #womenshealth #womenshealthinnovation #health #healthcare #healthcareinnovation #femhealth #digitalhealth #healthtech #biotech #pharma #startup #scaleup #venturecapital #research #ecosystem

✨🚀 Exciting news! 🚀✨ We’re featured in Femtech Insider, where the results of our latest pilot study, Fine Birth Clinical Trial-1 (FB-CT1), are highlighted! 🎉 Our Fine Birth device, which uses torsional wave elastography to accurately measure cervical consistency, is a game-changer in diagnosing threatened preterm labor (TPTL). A huge thanks to our CEO, Rubén Molina, and the entire team for their dedication! Special shoutouts to our collaborators and partners—together, we are making strides in improving maternal health! 💪 Check out the full article here! #Femtech #MaternalHealth #PretermBirth #Innovation #Healthcare #WomenInScience #Innitius #StartupLife #MedicalTechnology